Noxopharm Limited (ASX:NOX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0880
+0.0090 (11.39%)
Aug 5, 2026, 12:10 PM AEST

Noxopharm Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
3.42.822.46.015.435.61
Revenue Growth
20.37%17.52%-60.06%10.71%-3.20%-32.29%
Gross Profit
-0.95-1.45-0.53-4.64-2.35-6.95
Operating Income
-4.42-5.39-4.6-10.64-9.78-14.59
Net Income
-5.49-4.88-3.58-15.06-18.67-9.35
Earnings Per Share
-0.02-0.02-0.01-0.05-0.06-0.04
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
0.091.552.323.0114.0126.8
Total Debt
4.252.48--0.160.35
Net Cash (Debt)
-4.15-0.922.323.0113.8526.45
Net Cash Growth
---22.89%-78.28%-47.63%1159.30%
Net Cash Per Share
-0.01-0.000.010.010.050.10

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-7.27-5.82-0.68-10.95-13.73-8.85
Capital Expenditures
------
Free Cash Flow
-7.27-5.82-0.68-10.95-13.73-8.85
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
-27.98%-51.25%-22.28%-77.14%-43.27%-123.97%
Operating Margin
-130.04%-190.96%-191.71%-177.12%-180.14%-260.21%
Pretax Margin
-161.68%-173.15%-149.07%-250.52%-343.86%-166.66%
Profit Margin
-161.68%-173.15%-149.07%-250.52%-343.86%-166.66%
FCF Margin
-214.23%-206.48%-28.51%-182.13%-252.98%-157.81%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
7.965.598.042.0910.5033.15